L.P. Haveli Investments Buys Shares of BLND
L.P. Haveli Investments purchased 256,928 shares of BLND, valued at $436,777.6.
Key Points
- L.P. Haveli Investments acquired 256,928 shares of BLND at $1.70 per share on June 12, 2026.
- BLND shares are trading near $1.69, with various institutional investors adjusting their holdings.
- Analysts have maintained ratings with targets ranging from $1.9 to $5.0 for BLND.
On June 12, 2026, L.P. Haveli Investments made a significant move by purchasing 256,928 shares of BLND at an average price of $1.70 per share. This transaction was valued at approximately $436,777.6 and was not part of a pre-planned trading program.
Other Institutional Activity in BLND
Several other institutional investors have also been active in BLND. Lightspeed Management Company, L.L.C. held steady with 23,127,237 shares valued at about $39.3 million. BlackRock, Inc. trimmed its position by 65,730 shares, bringing its total to 16,287,185 shares worth approximately $27.7 million. Cypress Point Investment Management LP increased its stake by 2,689,208 shares, ending with 14,537,172 shares valued at $24.7 million. Haveli Investment Management LLC maintained its position with 10,848,873 shares valued at $18.4 million. Meanwhile, Vanguard Capital Management LLC and Vanguard Portfolio Management LLC each established new positions, holding 9,652,446 and 6,702,947 shares, respectively.
BLND Stock Snapshot
Shares of BLND are currently trading near $1.69. The stock has seen various movements from institutional investors, reflecting ongoing interest in its performance.
Insider Buying and Selling at BLND
BLND has seen insider activity with Haveli Investments, L.P. purchasing 650,000 shares on June 15, 2026, and 256,928 shares on June 12, 2026. Additionally, Eric Woersching bought 50,000 shares on June 11, 2026. On the same day, Gerald Chen, Erin Lantz, and Bryan Edmund Sullivan each sold 50,000 shares.
Analysts Set New Price Targets
Analyst firms have maintained their ratings for BLND, with Canaccord Genuity and Citizens both maintaining a 'buy' rating. Canaccord Genuity set a price target of $4.50 on May 15, 2026, while Citizens set a target of $4.00 on May 8, 2026. Keefe, Bruyette & Woods and UBS maintained 'hold' ratings with price targets of $1.90 and $2.00, respectively.
Bottom Line
L.P. Haveli Investments' purchase of BLND shares indicates a strategic interest in the company. While BLND's stock price is currently modest, the activity from both institutional investors and analysts suggests a keen interest in its potential. As always, it's important to remember that insider and institutional activity is backward-looking and may not reflect current positions.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.